Surmodics, Inc. - Common Stock (SRDX)
$35.90
0.36 (1.01%)
SRDX Stock Quote Delayed 30 Minutes
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024
SRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
507.41M
PE Ratio
-35.20
EPS
-1.02
Volume (Avg. Vol.)
46,495
Day's Range
$35.24 - $36.00
52-Week Range
$25.17 - $42.44
Dividend & Yield
N/A (N/A)
